Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cerebrospinal fluid levels of Alzheimer's disease biomarkers in middle-aged patients with type 1 diabetes.

Diabetologia - 1 Oct 2014

Ouwens D Margriet, van Duinkerken Eelco, Schoonenboom S Niki M, Herzfeld de Wiza Daniella, Klein Martin, van Golen Larissa, Pouwels Petra J W, Barkhof Frederik, Moll Annette C, Snoek Frank J, Teunissen Charlotte E, Scheltens Philip, Diamant Michaela

Abstract excerpt

AIMS/HYPOTHESIS: Type 1 diabetes is associated with moderate cognitive decline and cerebral alterations and may lead to an increased risk of dementia, including Alzheimer's disease. This study aimed to investigate the levels of risk markers for Alzheimer's disease in middle-aged patients with type 1 diabetes and controls, and their potential associations with cognitive and cerebral measures. METHODS: Levels of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Amyloid beta-Peptides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Diabetes Mellitus, Type 1

Share to Low Density Lipoprotein Receptor-Related Protein-1

Share to Macrophage Colony-Stimulating Factor

Share to Peptide Fragments

Share to tau Proteins

Source

Identifiers

PMID: 25034377
DOI: 10.1007/s00125-014-3333-6

Genes

LRP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cerebrospinal fluid levels of Alzheimer's disease biomarkers in middle-aged patients with type 1 diabetes.PMID 25034377Read ↗

Diabetes mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with the APOE4 genotype.Semantic proximity Read ↗

Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged AdultsSemantic proximity Read ↗

Navigation Between Alzheimer’s Disease (AD) and Its Various Pathophysiological Trajectories: The Pathogenic Link to Neuroimmunology—Genetics and NeuroinflammationSemantic proximity Read ↗

Spotlight on the Pathophysiological Trajectories Linked to Alzheimer’s Disease (AD): Blood-Brain Barrier (BBB); Neuroinflammation; APOE4 Allele and AD- Insulin Resistance (IR) Pathogenic LinkSemantic proximity Read ↗

Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular DamagesSemantic proximity Read ↗

The role of insulin resistance and APOE genotype on blood-brain barrier integrity in Alzheimer's disease.Semantic proximity Read ↗

Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent InsightsSemantic proximity Read ↗

The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer’s DiseaseSemantic proximity Read ↗

Amyloid-beta and tau proteins as biochemical markers of Alzheimer's diseaseSemantic proximity Read ↗

Plasma Biomarkers of Neurodegeneration and Neuroinflammation among Middle- Aged Adults in Western India: Implications of Racial and Geographical VariabilitySemantic proximity Read ↗

Brain [18F]FDG uptake patterns in type 2 diabetes: new phenotypes relating to biomarkers of cognitive impairmentSemantic proximity Read ↗

Neurocognitive consequences of diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.